Current Long-Term Pharmacotherapies for the Management of Obesity

Current Long-Term Pharmacotherapies for the Management of Obesity

Obesity is a serious and growing worldwide health challenge associated with type 2 diabetes mellitus, cardiovascular disease, osteoarthritis, some cancers, sleep apnea, asthma, and nonalcoholic fatty liver. The Korean Society for the Study of Obesity recommends that pharmacotherapy should be conside...

Full description

Bibliographic Details
Main Authors: Bo-Yeon Kim, Seon Mee Kang, Jee-Hyun Kang, Kyoung Kon Kim, Bomtaeck Kim, Seung Jun Kim, Yang-Hyun Kim, Jung-Hwan Kim, Jae Hyun Kim, Ga Eun Nam, Ji Yeon Park, Jang Won Son, Hye-Jung Shin, Tae Jung Oh, Hyug Lee, Eon-Ju Jeon, Sochung Chung, Yong Hee Hong, Chong Hwa Kim, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
Format: Article
Language:English
Published: Korean Society for the Study of Obesity 2020-06-01
Series:Journal of Obesity & Metabolic Syndrome
Subjects:
obesity
orlistat
lorcaserin
liraglutide
naltrexone/bupropion extended-release
phentermine/topiramate extended-release
Online Access:https://doi.org/10.7570/jomes20010

Internet

https://doi.org/10.7570/jomes20010

Similar Items